Randomized comparative clinical trial of itraconazole and selenium sulfide shampoo for the treatment of pityriasis versicolor. 1987

A del Palacio Hernanz, and S Delgado Vicente, and F Menéndez Ramos, and A Rodríguez-Noriega Belaustegui

Forty patients with pityriasis versicolor, fluorescence of involved areas under Wood's light, and positive microscopic identification of Malassezia furfur were randomly assigned to treatment with either oral itraconazole (200 mg once daily for five consecutive days) or 2.5% selenium sulfide shampoo (once daily application for seven days). Each treatment group consisted of 20 patients. On assessment three weeks after the end of treatment, all patients given itraconazole showed a response: 17 were healed, and three had mild residual lesions. Likewise, all patients in the selenium sulfide group responded to therapy: 16 were healed, and four had mild residual lesions. Tolerability, acceptability, and compliance were excellent with itraconazole. All 20 patients given the drug stated a preference for oral treatment. In the selenium sulfide group, five patients (25%) had adverse reactions attributable to the medication; one of these patients experienced an irritation severe enough to warrant the discontinuation of treatment on the third day. Ten patients in this group stated a preference for oral treatment.

UI MeSH Term Description Entries
D007654 Ketoconazole Broad spectrum antifungal agent used for long periods at high doses, especially in immunosuppressed patients. Nizoral,R-41400,R41,400,R41400,R 41400
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

A del Palacio Hernanz, and S Delgado Vicente, and F Menéndez Ramos, and A Rodríguez-Noriega Belaustegui
January 1984, Dermatologica,
A del Palacio Hernanz, and S Delgado Vicente, and F Menéndez Ramos, and A Rodríguez-Noriega Belaustegui
September 1956, Journal of the American Medical Association,
A del Palacio Hernanz, and S Delgado Vicente, and F Menéndez Ramos, and A Rodríguez-Noriega Belaustegui
January 2003, Indian journal of dermatology, venereology and leprology,
A del Palacio Hernanz, and S Delgado Vicente, and F Menéndez Ramos, and A Rodríguez-Noriega Belaustegui
December 2022, Germs,
A del Palacio Hernanz, and S Delgado Vicente, and F Menéndez Ramos, and A Rodríguez-Noriega Belaustegui
May 2007, Mycoses,
A del Palacio Hernanz, and S Delgado Vicente, and F Menéndez Ramos, and A Rodríguez-Noriega Belaustegui
January 1987, Mykosen,
A del Palacio Hernanz, and S Delgado Vicente, and F Menéndez Ramos, and A Rodríguez-Noriega Belaustegui
January 2003, Indian journal of dermatology, venereology and leprology,
A del Palacio Hernanz, and S Delgado Vicente, and F Menéndez Ramos, and A Rodríguez-Noriega Belaustegui
January 1987, Dermatologica,
A del Palacio Hernanz, and S Delgado Vicente, and F Menéndez Ramos, and A Rodríguez-Noriega Belaustegui
January 1999, Indian journal of dermatology, venereology and leprology,
A del Palacio Hernanz, and S Delgado Vicente, and F Menéndez Ramos, and A Rodríguez-Noriega Belaustegui
January 1987, Reviews of infectious diseases,
Copied contents to your clipboard!